avapro and leptin
avapro has been researched along with leptin in 9 studies
Research
Studies (9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Capuano, A; D'Amico, M; Di Filippo, C; Freda, F; Lampa, E; Petronella, P; Tufariello, E | 1 |
| Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Fogari, R; Gravina, A; Piccinni, MN; Pricolo, F; Ragonesi, PD; Salvadeo, SA | 1 |
| Ballesteros, S; Cachofeiro, V; de las Heras, N; Lahera, V; López-Farré, AJ; Martín-Fernández, B; Miana, M; Oubiña, MP | 1 |
| Kai, H; Morito, N; Saito, C; Tsuruoka, S; Usui, J; Yamagata, K; Yoh, K | 1 |
| Azushima, K; Dejima, T; Haku, S; Kanaoka, T; Kobayashi, R; Maeda, A; Ohki, K; Ohsawa, M; Tamura, K; Tsurumi-Ikeya, Y; Umemura, S; Uneda, K; Wakui, H; Yamashita, A | 1 |
| He, L; Ren, R; Sun, Y; Wang, F; Zhang, Y; Zhu, Y | 1 |
| Chang, F; Gao, R; Huangfu, W; Wang, M | 1 |
| Chen, M; Fang, D; Guo, R; Liu, D; Weng, J; Yang, S | 1 |
| Hattori, N; Matsuda, T; Nakatsuji, S; Nishiyama, N; Shimatsu, A; Yamada, A | 1 |
Trials
2 trial(s) available for avapro and leptin
| Article | Year |
|---|---|
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Irbesartan; Leptin; Lipids; Male; Middle Aged; Rosiglitazone; Telmisartan; Tetrazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2006 |
Effects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritis.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Body Mass Index; C-Reactive Protein; Chronic Disease; Cytokines; Female; Glomerulonephritis; Humans; Hypertension; Inflammation Mediators; Interleukin-6; Irbesartan; Leptin; Male; Middle Aged; Obesity; Prospective Studies; Proteinuria; Tetrazoles; Tumor Necrosis Factor-alpha | 2013 |
Other Studies
7 other study(ies) available for avapro and leptin
| Article | Year |
|---|---|
Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats.
Topics: Adipocytes; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Glycerolphosphate Dehydrogenase; Immunohistochemistry; Irbesartan; Leptin; Obesity; PPAR gamma; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2005 |
The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.
Topics: Adiponectin; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animal Feed; Animals; Aorta; Biphenyl Compounds; Glucose; Irbesartan; Leptin; Male; Metabolic Syndrome; Models, Biological; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles | 2009 |
Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders.
Topics: Adaptor Proteins, Signal Transducing; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Humans; Irbesartan; Leptin; Mice; Obesity; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles | 2014 |
Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Gastric Emptying; Gastroparesis; Gene Expression; Irbesartan; Leptin; Male; Microcirculation; Nitric Oxide Synthase; Rats; Receptor, Angiotensin, Type 2; Stomach; Tetrazoles; Triglycerides | 2014 |
ALDH2 improved irbesartan treatment efficacy among rats with hypertension.
Topics: Aldehyde Dehydrogenase, Mitochondrial; Animals; Antihypertensive Agents; Gene Expression Regulation; Hypertension; Irbesartan; Leptin; Male; Rats; Rats, Inbred SHR; Rats, Wistar; Up-Regulation | 2019 |
The antihypertensive effect of irbesartan in spontaneously hypertensive rats is associated with improvement of the leptin-adiponectin imbalance.
Topics: Adiponectin; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Irbesartan; Leptin; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2021 |
Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocytes.
Topics: Adipocytes; Adiponectin; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzoates; Humans; Inflammation; Irbesartan; Leptin; PPAR alpha; PPAR gamma; RNA, Messenger; Telmisartan | 2022 |